SEC Company Response from Bionano Genomics, Inc. (BNGO) (CIK 0001411690) (BNGO) — Apr 1, 2020
Bionano Genomics, Inc. (BNGO) (CIK 0001411690)
Date: April 1, 2020 · CIK: 0001411690 · Accession: 0001140361-20-007654
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237074
Letter
April 1, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Mr. Jeffrey Gabor
Re:
Bionano Genomics, Inc.
Registration Statement on Form S-1
File No. 333-237074
Acceleration Request
Requested Date:
Wednesday, April 1, 2020
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-237074) (the “Registration Statement”) to become effective on April 1, 2020, at 4:00 P.M., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its legal counsel may orally request via telephone call to the staff. This request for acceleration is subject to your receiving a telephone call prior to such time from our legal counsel, Cooley LLP, confirming this request. The Registrant hereby authorizes James Pennington of Cooley LLP to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, legal counsel to the Registrant, at (858) 550-6029.
Very truly yours,
Bionano Genomics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
April 1, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Mr. Jeffrey Gabor
Re:
Bionano Genomics, Inc.
Registration Statement on Form S-1
File No. 333-237074
Acceleration Request
Requested Date:
Wednesday, April 1, 2020
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests
that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-237074) (the “Registration Statement”) to become effective on April 1, 2020, at 4:00 P.M., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant or its legal counsel
may orally request via telephone call to the staff. This request for acceleration is subject to your receiving a telephone call prior to such time from our legal counsel, Cooley LLP, confirming this request. The Registrant hereby authorizes James
Pennington of Cooley LLP to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, legal counsel to the Registrant, at (858) 550-6029.
Very truly yours,
Bionano Genomics, Inc.
By:
/s/ R. Erik Holmlin, Ph.D.
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
cc:
James Pennington, Cooley LLP
Ivan Blumenthal, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Cliff Silverman, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.